Sponsor pipeline

Muhammad Furqan clinical trial pipeline

Get alerts when Muhammad Furqan's trials change

1 active trials 0 recruiting 2 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-09-04
Primary completion pushed: 2026-07 → 2027-01
Completion pushed: 2026-11 → 2027-04
NCT04699838 Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients… · Phase 2

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT04699838 Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients… Extensive Stage Small Cell Lung Cancer Active, Not Recruiting 2026-09-03

Disease areas by active trials

Lung Cancer (1) · Small Cell Lung Cancer (1)

Get alerts when Muhammad Furqan's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free